🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The Women's Malignancies Disease Group is Hiring! We have two open positions in Breast Cancer. Please share with anyone who may be interested bit.ly/3wqbC4i

Please join us for our 6th & last portion of the 2021 Lunch & Learn series featuring Sharon L Bober from Harvard Medical School, founder & director of the Sexual Health Program Registration is FREE: bit.ly/3Cmh6OO #bcsm #sexualhealth #breastcancer

Save the Date! The 3rd Annual "She Dunks on Endometrial Cancer" Virtual Symposium is Friday March 4th 2022 6:00-7:30pm EST - Zoom Visit SheDunksOnCancer.org for more info and to register!

Register for the 11th Biennial Johns Hopkins #BreastCancer Conference April 29 Key topics include availability of multiple new agents advances in immunotherapy, targeted therapies, further integration of genomic platforms into therapeutic decision making bit.ly/3LiHI82

Thank you ASCO for the opportunity, an honor to work with FabriceAndre and an exceptional panel

Thank you speakers and advocates! Hope you can join us for this free event May 12 #breastcancer #BrainMets #bcsm JHBreastGynResearch Johns Hopkins Kimmel Cancer Center

Register for the 11th Biennial Johns Hopkins #BreastCancer Conference April 29 Key topics include availability of multiple new agents advances in immunotherapy, targeted therapies, further integration of genomic platforms into therapeutic decision making bit.ly/3LiHI82

We have an open position for a Research Coordinator. Please share with anyone with an interest in research who would like to work with our fun and dynamic group! bit.ly/3OxDyMa

Great article featuring our own Dr. Cesar Santa-Maria and special mention of some of our clinical trials currently open/enrolling! bit.ly/3WOyI08 #bcsm #clinicaltrials

Researchers Johns Hopkins Kimmel Cancer Center are conducting an immunotherapy research study for patients with metastatic #breastcancer and an SF3B1 mutation. For more information, including how to find out if you are eligible for the PRISMM Trial, visit our webpage bit.ly/3mSaXYx

Researchers Johns Hopkins Kimmel Cancer Center are conducting an immunotherapy research study for patients with metastatic #breastcancer and a spliceosome mutation. For more information, including how to find out if you are eligible for the PRISMM Trial, visit our webpage bit.ly/3mSaXYx

Low-grade serous ovarian cancer: expert consensus report on the state of the science Consensus statement on low-grade serous ovarian cancer published in @IJGC feat our own Drs. Amanda Nickles Fader, MD and Stéphanie Gaillard #gynonc #GynCancer bit.ly/45qC4eF

Dr. Vered Stearns is here at #ASCOQLTY23 presenting findings from our MBC Hope at Hopkins Program for patients with #metastatic #breastcancer Poster is at K10. #bcsm

Where do we stand with the implementation of #liquidbiopsies in the #clinic? BR36 is a 2-stage #ctDNA response adaptive #clinicaltrial implementing ctDNA as an early endpoint of response to #Immunotherapy. Elsa Anagnostou Johns Hopkins Thoracic Oncology hopkinsmedicine.org/news/newsroom/… nature.com/articles/s4159…

Excited to welcome our CDC Cancer colleagues for our site visit to review all of our wonderful patient programs! #bcsm Johns Hopkins Kimmel Cancer Center Vered Stearns

Grateful to @RivkinCenter for this early-stage funding that enables our 1st foray into ovarian cancer. Our group (Alexa Tokofsky Gizem Yayli) is thrilled to work closely with co-I Dr. Stephanie Gaillard of the JHBreastGynResearch program- excited for future impact of this pilot study!

“The biggest change...has been [with] the era of ADCs. We’re seeing some great responses to these therapies, longer durations of benefit, and multiple different drugs are available” -Dr. Stéphanie Gaillard, on new NCCN guidelines for Gyn Cancers #gynCSM bit.ly/3VycJN6

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update led by Dr. Stéphanie Gaillard bit.ly/4aEVeky #gyncsm #gynoncology

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Clinical Insights A companion article that addresses some of the questions clinicians may face as they implement new recommendations. #gyncsm #GynOncology bit.ly/3CsMzFd

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer Guideline Update Dr. Stéphanie Gaillard & Dr. Bill Tew share updates to the guideline on neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer. bit.ly/4aHDapU #gyncsm #GynOncology